What is he best known for?
The fields of study he is best known for:
- Cancer
- Gene
- Internal medicine
Robert G. Bristow mainly investigates Cancer research, Prostate cancer, DNA repair, Molecular biology and Radiation therapy.
His Cancer research study incorporates themes from Radiosensitivity, Bioinformatics, Genome instability, Immunology and Gene.
His study in Prostate cancer is interdisciplinary in nature, drawing from both Copy number analysis, Prostate, Oncology and Clinical trial.
His studies deal with areas such as Cancer cell, Cell cycle, DNA damage and Homologous recombination as well as DNA repair.
Robert G. Bristow has researched Molecular biology in several fields, including Pre-replication complex, Eukaryotic DNA replication, RAD51 and Cell biology.
His research in Radiation therapy intersects with topics in Hypoxia and Urology.
His most cited work include:
- Hypoxia and metabolism. Hypoxia, DNA repair and genetic instability. (765 citations)
- Pan-cancer analysis of whole genomes (538 citations)
- Gold Nanoparticles as Radiation Sensitizers in Cancer Therapy (416 citations)
What are the main themes of his work throughout his whole career to date?
Robert G. Bristow spends much of his time researching Prostate cancer, Internal medicine, Oncology, Radiation therapy and Cancer research.
His biological study deals with issues like Prostate, which deal with fields such as Nuclear medicine.
His work deals with themes such as Biomarker, Androgen deprivation therapy, Pathological and Biochemical recurrence, which intersect with Oncology.
His Radiation therapy research incorporates themes from Clinical trial, Toxicity and Urology.
His studies in Cancer research integrate themes in fields like Radiosensitivity, Hypoxia, Immunology, Radioresistance and DNA repair.
His DNA repair research integrates issues from Molecular biology, Cell cycle, DNA damage and Homologous recombination.
He most often published in these fields:
- Prostate cancer (63.98%)
- Internal medicine (45.79%)
- Oncology (43.30%)
What were the highlights of his more recent work (between 2017-2021)?
- Prostate cancer (63.98%)
- Oncology (43.30%)
- Internal medicine (45.79%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Prostate cancer, Oncology, Internal medicine, Cancer research and Radiation therapy.
Robert G. Bristow interconnects Transcriptome, Prostate, Disease and Genome instability in the investigation of issues within Prostate cancer.
Robert G. Bristow combines subjects such as Regulation of gene expression and DNA repair with his study of Genome instability.
His Oncology research includes themes of Confidence interval, Androgen deprivation therapy, Carcinoma, Biomarker and Cohort.
His study in Cancer research is interdisciplinary in nature, drawing from both Hypoxia, Tumor hypoxia, Gene, Lung cancer and PTEN.
His work carried out in the field of Radiation therapy brings together such families of science as Biochemical recurrence, Medical physics, In vivo and Urology.
Between 2017 and 2021, his most popular works were:
- Pan-cancer analysis of whole genomes (538 citations)
- Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017 (333 citations)
- Widespread and Functional RNA Circularization in Localized Prostate Cancer (150 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Gene
- Internal medicine
The scientist’s investigation covers issues in Prostate cancer, Prostate, Internal medicine, Oncology and Cancer research.
His Prostate cancer research includes themes of Hypoxia, Clinical trial, Transcriptome, Genome instability and Computational biology.
In Prostate, Robert G. Bristow works on issues like Metastasis, which are connected to Hazard ratio, Area under the curve and Hormone therapy.
His research in Cancer research intersects with topics in Mutation, Regulation of gene expression and Gene.
His research integrates issues of Bladder cancer and Stage in his study of Radiation therapy.
The study incorporates disciplines such as Cancer cell and Adenocarcinoma in addition to Carcinoma.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
